Geoffrey McDonough appointed CEO of Sobi
This article was originally published in Scrip
Swedish Orphan Biovitrum has appointed Geoffrey McDonough president and CEO, effective as of August 2011. He will succeed Kennet Rooth who has been acting CEO since January 2011. Mr McDonough is currently president of Europe, Middle East and Africa for Genzyme.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.